Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON injection as first-line prophylaxis for episodic cluster headache
NL-OMON48495Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of verapamil and saline in Cluster Headache (CH), sponsored by Leiden University Medical Center. Primary endpoint: Total dose of verapamil used during the study period. Started Jul 2019; status: active, not recruiting.
02
Drugs
verapamilsaline
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NL-OMON48495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48495.